Stock Otinova®
Why Otinova?
Otinova’s aluminium acetate and acetic acid-based formula provides an antifungal and antibacterial effect, with otitis externa as its indication for use. It is listed by NICE as a topical ear preparation for otitis externa (PIP code: 4163143).
We have received feedback from ENT experts who frequently report fast relief of itching and inflammation. We are also pleased to announce that Otinova has recently been awarded as ‘Highly commended’ in the 2026 pharmacy product of the year under ‘ear care’.
If you think Otinova could be of use, please fill out the form below to receive literature and samples.
Burow’s solution
Burow’s solution has a long and well-evidenced history as a highly effective treatment for external otitis, commonly known as swimmer’s ear. Developed in the 19th century, it works by producing a solution of aluminium acetate with proven antimicrobial properties against a broad range of bacterial and fungal strains, including antibiotic-resistant bacteria such as MRSA.
In clinical studies, patients treated with Burow’s solution achieved complete symptom relief in an average of 9.36 days, compared to 11.06 days for those using conventional antibiotic and steroid ear drops. The only side effects reported in human studies were an occasional mild stinging sensation. Otinova delivers this trusted, tried-and-tested formulation as a convenient over-the-counter ear spray.
Click here to read more on Burow’s solution.
What happens with your information?
This information is securely stored and used for the sole purposes of responding to your enquiry. Unless the nature of your enquiry is medical, we do not retain this personal information, and your enquiry will be deleted no later than 6 months after your initial enquiry. For more information please read our Privacy Policy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
